福元医药：公司会在定期报告中依据相关法律法规披露股东人数以保证所有投资者平等获悉公司信息

Core Viewpoint - Fuyuan Pharmaceutical (601089) emphasizes its commitment to fair information disclosure by stating that it will disclose the number of shareholders in its periodic reports to ensure all investors receive equal access to company information [1] Group 1 - The company responded to investor inquiries on November 5 regarding its information disclosure practices [1] - Fuyuan Pharmaceutical aims to adhere to relevant laws and regulations in its reporting [1] - The company highlights the importance of equal information access for all investors [1]